RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALKS
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Alkermes plc stock after gaining 0.165%
(Updated on Jul 03, 2024)

Sell candidate since Jun 28, 2024 Gain 0.54% PDF

The Alkermes plc stock price gained 0.165% on the last trading day (Wednesday, 3rd Jul 2024), rising from $24.19 to $24.23. During the last trading day the stock fluctuated 1.72% from a day low at $24.12 to a day high of $24.54. The price has fallen in 6 of the last 10 days and is down by -0.78% for this period. Volume fell on the last day by -680 thousand shares and in total, 508 thousand shares were bought and sold for approximately $12.32 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.55% during the next 3 months and, with a 90% probability hold a price between $22.38 and $24.32 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALKS Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Alkermes plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $24.28 and $24.26. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 20, 2024, and so far it has fallen -3.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Alkermes plc stock

Alkermes plc finds support from accumulated volume at $24.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.415 between high and low, or 1.72%. For the last week the stock has had daily average volatility of 2.10%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALKS) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Alkermes plc to open at $24.30, and during the day (based on 14 day Average True Range), to move between $23.60 and $24.86, which gives a possible trading interval of +/-$0.627 (+/-2.59%) up or down from last closing price. If Alkermes plc takes out the full calculated possible swing range there will be an estimated 5.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $24.19 (0.17%) than the resistance at $24.42 (0.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alkermes plc stock A Buy?

Alkermes plc holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.090 Strong Sell Candidate Unchanged

Predicted Opening Price for Alkermes plc of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$24.30 ( 0.268%) $24.23

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALKS

Fibonacci Support & Resistance Levels

Level Price
R3 24.71 1.98%
R2 24.55 1.33%
R1 24.45 0.92%
Price 24.23
S1 24.14 -0.386%
S2 24.04 -0.790%
S3 23.88 -1.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 26.73 10.32%
R2 24.95 2.97%
R1 24.42 0.784%
Price 24.23
S1 24.19 -0.165%
S2 24.10 -0.537%
S3 24.01 -0.91%

FAQ

What is the symbol for Alkermes plc Stock and on which exchange is it traded?
The symbol for Alkermes plc is ALKS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alkermes plc Stock?
Alkermes plc holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Alkermes plc Stock?
Alkermes plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alkermes plc Stock.

What's the current price of Alkermes plc Stock?
As of the end of day on the Jul 03, 2024, the price of an Alkermes plc (ALKS) share was $24.23.

What is the 52-week high and low for Alkermes plc Stock?
The 52-week high for Alkermes plc Stock is $32.88 and the 52-week low is $22.01.

What is the market capitalization of Alkermes plc Stock?
As of the Jul 03, 2024, the market capitalization of Alkermes plc is 4.127B.

When is the next earnings date for Alkermes plc?
The upcoming earnings date for Alkermes plc is Jul 24, 2024.
Click to get the best stock tips daily for free!

About Alkermes plc

Alkermes plc Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre... ALKS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT